In addition, CAAR-T cells that express extracellular muscle-specific receptor kinase (MuSK) domains were designed to delete pathogenic MuSK-specific B cells, that drive MG (Table 6) (246). The gene discussed is MUSK; the disease is myasthenia gravis.